African Countries Eye Russia's Vaccine
This is a Russia news story, published by MSN, that relates primarily to Orthopoxvac news.
Russia news
For more Russia news, you can click here:
more Russia newsNews about vaccine development
For more vaccine development news, you can click here:
more vaccine development newsMSN news
For more news from MSN, you can click here:
more news from MSNAbout the Otherweb
Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like this article about vaccine development, you might also like this article about
Russian mpox vaccines. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest vaccine Russia news, mpox outbreak news, news about vaccine development, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
Russian vaccineReuters
•Russia says African, ex-Soviet countries interested in its mpox vaccine
81% Informative
Several African and ex-Soviet countries have expressed interest in buying Russia 's vaccine against smallpox and mpox viruses.
The vaccine, called Orthopoxvac , was developed by the Vektor laboratory in Siberia .
Mpox is a viral infection that spreads through close contact, causing flu-like symptoms and pus-filled lesions.
VR Score
91
Informative language
97
Neutral language
75
Article tone
formal
Language
English
Language complexity
62
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
no external sources
Source diversity
no sources
Affiliate links
no affiliate links